Article: Low cost, hi-resolution encoder.

Article: JSPL seeks ML, to commission first phase by 2010.
PTI - The Press Trust of India Ltd.;  January 8, 2009 ;     632 words ...JSPL seeks ML, to commission first phase by 2010 Bhubaneswar, Jan ... project in Orissa, the first phase of which is slated for ... Orissa) and asked for ML," Dalwai told reporters ... Stating that the first phase of the project would be ...

Article: India: JSPL seeks ML, to commission first phase by ...
TendersInfo;  January 9, 2009 ;     508 words ...Byline: prashant03 Optimistic of commissioning the first phase of its proposed 6mtpa steel mill in Orissa&aposs Angul ... Jindal Steel and Power Limited (JSPL) had sought mining lease (ML) for expediting the project. JSPL&aposs executive Vice ...

Article: Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) ...
PR Newswire;  July 31, 2006 ;     700+ words ... ... recall of Ultravist 370 mgI/ml as well as the insufficient results of the clinical phase III trial with sargramostim ... recall of Ultravist 370 mgI/ml KPMG Deutsche Treuhand-Gesellschaft ... recall of Ultravist 370 mgI/ml and the sargramostim clinical ...

Article: Adrenal function and use of intralesional triamcinolone acetonide ...
Journal of Drugs in Dermatology;  September 1, 2009 ;     700+ words ... ... administered ACTH. Serum blood draws of 3 mL will be done at baseline and six-week intervals ... between blood draws. Condition Intervention Phase Alopecia Areata Drug: Triamcinolone Acetonide 10 mg/mL Phase 2 Study ID Numbers: 0609M9189 ClinicalTrials ...

Article: Effect of menstrual phase on the acetate correction factor ...
Applied Physiology, Nutrition, and Metabolism;  December 1, 2003 ;     700+ words ... ... each of three menstrual phases (early follicular [EF ... LF], and midluteal [ML] phase) from the fractional recovery ... EF and LF or the LF and ML phases, but the correction factor derived in the ML phase was significantly lower ...

Article: Pharmasset Reports Phase 2 HIV Study Results of ...
PR Newswire;  February 12, 2004 ;     700+ words ... ... today announced results from a Phase 2 study of Reverset, which ... levels > 5,000 copies/ml were enrolled in a 10-day ... 28 and 38 in the follow-up phase. Plasma samples for virus genotyping ... dosing and again on day 10. Phase 2 Study Results Preliminary ...

Article: [pounds sterling]16m Aids cash for ML.
The Evening Standard (London, England);  February 19, 2002 ;     642 words ... ... today by the Department of International Development. ML Laboratories' research and trials of its Emmelle vaginal ... programme will include large-scale effectiveness trials and Phase III tests. ML Laboratories' shares today advanced by 11/2p to 41p ...